Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention
暂无分享,去创建一个
Mary Wilson | Iain Buchan | Susan M Astley | Jack Cuzick | Paula Stavrinos | Jane Warwick | Sarah Sahin | Alan Hufton | Ursula Beetles | Anthony Howell | I. Buchan | S. Astley | J. Cuzick | J. Warwick | A. Howell | R. Warren | D. Evans | W. Newman | J. Sergeant | H. Mcburney | M. Harvie | U. Beetles | Michelle Harvie | P. Stavrinos | S. Ingham | Ruth Warren | D Gareth R Evans | William G Newman | Sarah Ingham | Helen McBurney | Barbara Eckersley | Jamie C Sergeant | A. Hufton | B. Eckersley | S. Sahin | M. Wilson | D. Evans | D. Evans
[1] S. Moss,et al. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland , 2011, British Journal of Cancer.
[2] R. Wilkins. Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.
[3] D. Evans,et al. Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.
[4] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.
[5] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[6] A. Gatrell,et al. Uptake of screening for breast cancer in south Lancashire. , 1998, Public health.
[7] S. Cummings,et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. , 2007, Endocrine-related cancer.
[8] J Benichou,et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.
[9] S. Astley,et al. Increasing participant recruitment into large-scale screening trials: experience from the CADET II study , 2009, Journal of medical screening.
[10] K. Heusinger,et al. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial , 2010, Breast Cancer Research and Treatment.
[11] S. Ciatto,et al. Breast density as a determinant of interval cancer at mammographic screening , 2004, British Journal of Cancer.
[12] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[13] J. Haines,et al. Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.
[14] Karla Kerlikowske,et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.
[15] C. Hudis,et al. Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women , 2011, Breast Cancer Research and Treatment.
[16] J. Wardle,et al. Socioeconomic variation in participation in colorectal cancer screening , 2002, Journal of medical screening.
[17] Deborah Hughes,et al. Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.
[18] A. Evans,et al. NHSBSP type 1 interval cancers: a scientifically valid grouping? , 2007, Clinical radiology.
[19] Jinbo Chen,et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. , 2006, Journal of the National Cancer Institute.
[20] A Howell,et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.
[21] Mary Wilson,et al. Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view , 2008, Breast Cancer Research.
[22] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[23] Karla Kerlikowske,et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.
[24] S G Thompson,et al. Screening for abdominal aortic aneurysms: the effects of age and social deprivation on screening uptake, prevalence and attendance at follow-up in the MASS trial. , 2004, Journal of medical screening.
[25] David A. Hinds,et al. Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.
[26] David Tritchler,et al. Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.
[27] P. Boyle,et al. Screening Uptake in a Well-Established Diabetic Retinopathy Screening Program , 2008, Diabetes Care.
[28] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[29] Susan M Astley,et al. Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening Program. , 2006, Radiology.
[30] Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial. , 2000, Revue d'epidemiologie et de sante publique.
[31] M. Parmar,et al. Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study , 2008, BMJ : British Medical Journal.
[32] A. Jemal,et al. Global Cancer Statistics , 2011 .
[33] J. Pankow,et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. , 1997, Journal of the National Cancer Institute.
[34] P. Porter,et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.
[35] M. Gail. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. , 2009, Journal of the National Cancer Institute.
[36] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[37] Stephen W Duffy,et al. A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.